Precipio, Inc. — Director's Dealing 2014

Nov 6, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TRANSGENOMIC INC (TBIO)
CIK: 0001043961
Period of Report: 2014-11-04

Reporting Person: Richards Leon (Chief Accounting Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-11-04	Stock Option (Right to Buy)	$3.15	A	20000	Acquired	2024-11-04	Common Stock (20000)	Direct
2014-11-04	Stock Appreciation Rights	$3.15	A	15000	Acquired	2024-11-04	Common Stock (15000)	Direct

Footnotes

F1: The option was granted on 11/4/2014 and is exercisable as it vests. The option vests over a three year period, with 1/3 of the shares subject to the option vesting on each one year anniversary of the date of grant, subject to the reporting person's continued employment with the issuer on each such date.

F2: The stock appreciation rights were granted on 11/4/2014 and are exercisable as they vest. The stock appreciation rights vest over a three year period, with 34% of the shares subject to the stock appreciation rights vesting on the first anniversary of the date of grant and the balance vesting ratably over the remaining 24 months, subject to the reporting person's continued employment with the issuer on each such date.